Stock listing
Frankfurt:KH6 NewAmsterdam Pharma Company N.V. Aktie
German listing (Frankfurt) of NewAmsterdam Pharma Company N.V. · home listing NASDAQ:NAMS
Follow NewAmsterdam Pharma Company N.V. into a list and get an email when it puts out news.
Share price · FWB:KH6
€17.74 EUR -0.48 (-2.6%)
Close on Nov 13, 2026
- Day range
- €17.15 – €17.74 EURNov 13, 2026
- Market cap
- €2.07B EURAt the close on Nov 13, 2026 · price × 116.9M shares outstanding
- 52-week range
- €16.56 – €35.28 EURLowest and highest trades, Nov 14, 2025 – Nov 13, 2026
- Traded on an average day
- €2,269 EURMedian day 0 shares · 37 days with no trades · last 3 months, Aug 13, 2026 – Nov 5, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NAMS · Home | $19.46 USD | -0.68 (-3.4%) | 1,682,603 | $19.94 | $20.54 | $19.45 | $20.14 | Close on Nov 16, 2026 |
| Dusseldorf:KH6 | €17.67 EUR | -0.58 (-3.2%) | — | €18.16 | €18.26 | €17.67 | €18.25 | Close on Nov 16, 2026 |
| Frankfurt:KH6 | €17.74 EUR | -0.48 (-2.6%) | — | €17.15 | €17.74 | €17.15 | €18.22 | Close on Nov 13, 2026 |
Daily closes
Last 3 months, Aug 13, 2026 – Nov 5, 2026 · FWB:KH6 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €17.86 | -1.198 | -6.3% | €17.81 | €18.00 | €17.77 | 105 | |
| €19.06 | +2.181 | +12.9% | €16.94 | €19.11 | €16.79 | 105 | |
| €16.88 | -0.685 | -3.9% | €16.71 | €16.88 | €16.56 | 0 | |
| €17.57 | -0.64 | -3.5% | €17.57 | €17.57 | €17.57 | 0 | |
| €18.21 | -0.375 | -2.0% | €18.12 | €18.21 | €18.10 | 74 | |
| €18.58 | +0.985 | +5.6% | €18.47 | €18.60 | €18.35 | 590 | |
| €17.60 | +0.671 | +4.0% | €17.84 | €18.02 | €17.37 | 30 | |
| €16.92 | +0.112 | +0.7% | €16.94 | €16.94 | €16.92 | 0 | |
| €16.81 | -1.62 | -8.8% | €17.30 | €17.30 | €16.71 | 126 | |
| €18.43 | -0.127 | -0.7% | €18.35 | €18.48 | €18.32 | 1,042 | |
| €18.56 | -0.067 | -0.4% | €18.26 | €18.61 | €18.07 | 0 | |
| €18.63 | +1.154 | +6.6% | €18.34 | €18.64 | €18.12 | 0 | |
| €17.47 | +0.672 | +4.0% | €17.47 | €17.47 | €17.47 | 0 | |
| €16.80 | -0.679 | -3.9% | €16.79 | €16.81 | €16.77 | 0 | |
| €17.48 | +0.147 | +0.8% | €17.44 | €17.48 | €17.41 | 0 | |
| €17.33 | -0.392 | -2.2% | €16.99 | €17.40 | €16.91 | 0 | |
| €17.72 | -0.574 | -3.1% | €17.29 | €17.73 | €17.24 | 0 | |
| €18.30 | -0.263 | -1.4% | €18.22 | €18.39 | €18.20 | 0 | |
| €18.56 | -0.169 | -0.9% | €18.47 | €18.65 | €18.45 | 0 | |
| €18.73 | -0.228 | -1.2% | €17.92 | €18.83 | €17.92 | 440 | |
| €18.96 | +0.022 | +0.1% | €18.96 | €18.96 | €18.96 | 500 | |
| €18.94 | -0.753 | -3.8% | €19.03 | €19.07 | €18.85 | 0 | |
| €19.69 | -1.33 | -6.3% | €19.34 | €19.74 | €19.10 | 0 | |
| €21.02 | +0.519 | +2.5% | €19.78 | €21.22 | €19.62 | 100 | |
| €20.50 | -0.52 | -2.5% | €21.20 | €21.41 | €20.44 | 218 | |
| €21.02 | +1.064 | +5.3% | €22.33 | €22.46 | €20.92 | 350 | |
| €19.96 | -0.489 | -2.4% | €19.95 | €20.03 | €19.93 | 300 | |
| €20.45 | +1.243 | +6.5% | €19.89 | €20.47 | €19.71 | 0 | |
| €19.20 | -0.266 | -1.4% | €20.76 | €21.05 | €18.80 | 85 | |
| €19.47 | +0.434 | +2.3% | €19.14 | €19.54 | €19.11 | 94 | |
| €19.03 | -0.731 | -3.7% | €19.00 | €19.13 | €19.00 | 0 | |
| €19.77 | +0.35 | +1.8% | €19.52 | €19.77 | €19.36 | 0 | |
| €19.42 | -1.091 | -5.3% | €18.90 | €19.47 | €18.87 | 0 | |
| €20.51 | +1.891 | +10.2% | €20.52 | €20.60 | €19.54 | 68 | |
| €18.62 | -1.01 | -5.1% | €18.16 | €18.67 | €18.13 | 200 | |
| €19.63 | +1.106 | +6.0% | €17.63 | €19.64 | €17.42 | 541 | |
| €18.52 | -0.105 | -0.6% | €17.43 | €18.53 | €17.24 | 192 | |
| €18.62 | -0.274 | -1.4% | €18.54 | €18.68 | €18.53 | 54 | |
| €18.90 | +0.177 | +0.9% | €18.87 | €18.99 | €18.85 | 270 | |
| €18.72 | -0.331 | -1.7% | €18.07 | €18.76 | €18.06 | 1,406 | |
| €19.05 | -2.069 | -9.8% | €19.05 | €19.05 | €19.05 | 0 | |
| €21.12 | -0.646 | -3.0% | €21.11 | €21.15 | €21.10 | 0 | |
| €21.77 | +0.306 | +1.4% | €21.77 | €21.77 | €21.77 | 0 | |
| €21.46 | +0.069 | +0.3% | €21.46 | €21.46 | €21.46 | 0 | |
| €21.39 | -0.161 | -0.7% | €21.33 | €21.39 | €21.13 | 0 | |
| €21.55 | +0.568 | +2.7% | €21.14 | €21.72 | €21.09 | 0 | |
| €20.99 | +0.255 | +1.2% | €20.65 | €21.08 | €20.65 | 0 | |
| €20.73 | -1.033 | -4.7% | €20.92 | €20.96 | €20.73 | 0 | |
| €21.76 | -0.652 | -2.9% | €21.32 | €21.84 | €21.02 | 0 | |
| €22.42 | -0.665 | -2.9% | €22.05 | €22.70 | €22.01 | 252 | |
| €23.08 | +0.539 | +2.4% | €22.53 | €23.36 | €22.39 | 0 | |
| €22.54 | +0.121 | +0.5% | €22.30 | €22.62 | €22.25 | 0 | |
| €22.42 | -0.639 | -2.8% | €22.02 | €22.59 | €21.79 | 0 | |
| €23.06 | -0.083 | -0.4% | €22.76 | €23.32 | €22.74 | 0 | |
| €23.14 | -0.524 | -2.2% | €22.79 | €23.24 | €22.76 | 82 | |
| €23.67 | +0.471 | +2.0% | €23.28 | €23.70 | €23.26 | 0 | |
| €23.20 | +0.822 | +3.7% | €22.24 | €23.47 | €22.21 | 0 | |
| €22.37 | +0.019 | +0.1% | €22.23 | €22.40 | €22.10 | 0 | |
| €22.35 | +0.009 | 0.0% | €22.22 | €22.42 | €22.14 | 0 | |
| €22.35 | -1.209 | -5.1% | €22.12 | €22.41 | €22.11 | 0 | |
| €23.55 | +0.43 | +1.9% | €23.15 | €23.89 | €23.01 | 0 |
- Ticker
- Frankfurt:KH6
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 6, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Latest earnings call · Aug 5, 2026
NewAmsterdam Pharma (NASDAQ:NAMS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 4, 2026
Investor Presentation (November 2026)
Investor deck · 40 slides
Calls
Replays
NewAmsterdam Pharma (NASDAQ:NAMS) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 9:00 AM ET
Watch TranscriptNewAmsterdam Pharma (NASDAQ:NAMS) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:00 AM ET
Watch Transcript
Latest news
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
Nov 4, 2026
Closed €19.06 (+12.9%) on Nov 4, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in November
Nov 3, 2026
Closed €16.88 (-3.9%) on Nov 3, 2026
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
Sep 29, 2026
Closed €20.45 (+6.5%) on Sep 29, 2026
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Sep 21, 2026
Closed €19.42 (-5.3%) on Sep 22, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September
Sep 2, 2026
Closed €20.99 (+1.2%) on Sep 2, 2026
NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
Aug 26, 2026
Closed €22.54 (+0.5%) on Aug 26, 2026
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
Jul 29, 2026
Closed €24.17 (-6.9%) on Jul 29, 2026
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
Jun 3, 2026
Closed €26.72 (+1.9%) on Jun 3, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
May 11, 2026
Closed €31.79 (+11.0%) on May 11, 2026
Financings
Public offering of ordinary shares and pre-funded warrants
Dec 11, 2024
Made bigger: about US$416.5M · US$24.5 a share · Jefferies +5
Dealers: Jefferies (co-lead), Goldman Sachs & Co. (co-lead), Leerink Partners (co-lead), TD Cowen (co-lead), Guggenheim Securities (co-lead), William Blair (co-lead)
Decks
Investor Presentation (November 2026)
Investor deck · 40 slides · Nov 4, 2026
Investor Presentation (August 2026)
Investor deck · 40 slides · Aug 10, 2026
Investor Day (August 2026)
Investor day · 143 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 6 slides · May 7, 2026
NewAmsterdam Pharma Company N.V. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 93 in all · newest Nov 6, 2026 · oldest 2022
- Calls
- 2 calls with a replay · 2 with a transcript · latest Aug 5, 2026
- Decks
- 33 decks · latest Nov 4, 2026
Where NewAmsterdam Pharma Company N.V. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NAMS · Home listing | NASDAQ | United States | USD |
| gettex:KH6 | gettex | Germany | EUR |
| LS Exchange:A3DUAC | LS Exchange | Germany | EUR |
| Tradegate:KH6 | Tradegate | Germany | EUR |
| BOATS:NAMS | BOATS | United States | USD |
| Lang & Schwarz:A3DUAC | Lang & Schwarz | Germany | EUR |
| Dusseldorf:KH6 | Dusseldorf | Germany | EUR |
| Frankfurt:KH6 · This page | Frankfurt | Germany | EUR |
| Hamburg:KH6 | Hamburg | Germany | EUR |
| Munich:KH6 | Munich | Germany | EUR |
| Stuttgart:KH6 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about NewAmsterdam Pharma Company N.V.